+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In Vitro Lung Model Market to 2027- Global Analysis and Forecasts by Type; Application and Geography

  • ID: 4876870
  • Report
  • November 2019
  • Region: Global
  • 148 Pages
  • The Insight Partners
UP TO OFF until Jun 30th 2022
The global in vitro lung model market is expected to reach US$ 701.81 Mn in 2027 from US$ 185.80 Mn in 2018. The market is estimated to grow with a CAGR of 16.2% from 2019-2027.

Driving factors of the in vitro lung model are significant growth in research funding, and increasing adoption of 3d model systems for in vitro studies. Also, growing research on lung diseases is likely to have a positive impact on the growth of the market in the coming years. Besides, rising healthcare expenditure, and advancements in cell culture techniques is likely to have a positive effect on the growth of the market in the forecast years.

The cases of asthma, lung cancer, and COPD has been growing across the globe at a significant rate. Thus there is a growing need to study lung diseases specifically. Since early 2010’s the practices of creating lab-grown organ buds, mostly referred to as ‘organoids’, have become more popular. These organ buds are miniature organ-like structures that are maintained in the lab, and researchers are able to grow these organoids, which resembles human body tissues. Lung diseases, like idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), is a significant cause of death and illness worldwide. A recently published report by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California developed a new system for building lung 3D organoids to model lung disease. Moreover, Lung cancer cell lines have made a significant contribution to lung cancer research and biomedical discovery. The high similarities between lung cancer cell lines and the lung tumor helps in discovering new drug molecules. Thus the growing research on lung diseases is expected to offer broad growth opportunities for the in vitro lung model market at the global level.

The global in vitro lung model market is segmented by type, and application. On the basis of type, the market is segmented into 2D and 3D. The 3D segment is expected to dominate the type segment market as 3D cell culture gives better phenotypes insights which are poorly reproduced in conventional 2D cell culture, Based on the application, market is segmented into drug screening, toxicology, 3d model development, physiologic research, stem cell research, and regenerative medicine. Toxicology segment is expected to dominate the application segment during the forecast period.

Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), American Society of Clinical Oncology, American Type Culture Collection, Centers for Disease Control and Prevention, Canadian Lung Association and others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the in vitro lung model market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global in vitro lung model market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global In Vitro Lung Model Market - By Type
1.3.2 Global In Vitro Lung Model Market - By Application
1.3.3 Global In Vitro Lung Model Market - By Geography
2. In Vitro Lung Model Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In Vitro Lung Model- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 In Vitro Lung Model Market in North America: PEST Analysis
4.2.2 In Vitro Lung Model Market in Europe: PEST Analysis
4.2.3 In Vitro Lung Model Market in APAC: PEST Analysis
4.2.4 In Vitro Lung Model Market in MEA: PEST Analysis
4.2.5 In Vitro Lung Model Market - South and Central America PEST Analysis
4.3 Expert Opinion
5. Global In Vitro Lung Model Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Significant Growth in Research Funding
5.1.2 Increasing Adoption Of 3D Model Systems For In Vitro Studies
5.2 Key Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Key Market Opportunity
5.3.1 Rising Research on Lung Diseases
5.4 Future Trend
5.4.1 Increasing Number of Start Up Companies
5.5 Impact Analysis
6. In Vitro Lung Model Market - Global Analysis
6.1 Global In Vitro Lung Model Market Revenue Forecasts And Analysis
6.2 Global In Vitro Lung Model Market, By Geography - Forecasts And Analysis
6.3 Positioning Of Key Players
7. In Vitro Lung Model Market Analysis And Forecasts To 2027 - Type
7.1 Overview
7.2 Global In Vitro Lung Model Market, By Type 2018 & 2027 (%)
7.3 2D Market
7.3.1 Overview
7.3.2 Global 2D Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 3D Market
7.4.1 Overview
7.4.2 Global 3D Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 In House Market
7.4.3.1 Overview
7.4.3.2 Global In House Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Commercial Market
7.4.4.1 Overview
7.4.4.2 Global Commercial Market Revenue and Forecasts to 2027 (US$ Mn)
8. In Vitro Lung Model Market Analysis And Forecasts To 2027 - Application
8.1 Overview
8.2 Global In Vitro Lung Model Market, By Application 2018 & 2027 (%)
8.3 Drug Screening Market
8.3.1 Overview
8.3.2 Drug Screening Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Toxicology Market
8.4.1 Overview
8.4.2 Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 3D Model Development Market
8.5.1 Overview
8.5.2 Global 3D Model Development Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Physiological Research Market
8.6.1 Overview
8.6.2 Global Physiological Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Stem Cell Research Market
8.7.1 Overview
8.7.2 Global Stem Cell Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Regenerative Medicine Market
8.8.1 Overview
8.8.2 Global Regenerative Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
9. In Vitro Lung Model Market Revenue And Forecasts To 2027 - Geographical Analysis
9.1 North America In Vitro Lung Model Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.3.1 North America 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.4 North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.5 North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
9.1.6 US In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 US In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 US In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.2.1 US 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 US In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.7 Canada In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Canada In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Canada In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.2.1 Canada 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Canada In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.8 Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.2.1 Mexico 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2 Europe In vitro lung model Market Revenue and Forecasts To 2027
9.2.1 Overview
9.2.2 Europe In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.2.1 Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.2.1.1 Europe 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.2.2 Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.3 Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
9.2.4 Germany In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.4.1 Germany In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.4.2 Germany In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.4.2.1 Germany 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.4.3 Germany In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.5 UK In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.5.1 UK In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.5.2 UK In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.5.2.1 UK 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.5.3 UK In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.6 France In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 France In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.2 France In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.6.2.1 France 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.6.3 France In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.7 Spain In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 Spain In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.2 Spain In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.7.2.1 Spain 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.7.3 Spain In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.8 Italy In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 Italy In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.2 Italy In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.8.2.1 Italy 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.8.3 Italy In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts To 2027
9.3.1 Overview
9.3.2 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.3.1 Asia Pacific 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.4 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.5 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
9.3.6 China In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.1 China In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.2 China In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.6.2.1 China 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.6.3 China In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.7 Japan In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 Japan In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.2 Japan In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.7.2.1 Japan 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.7.3 Japan In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.8 India In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.1 India In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.2 India In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.8.2.1 India 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.8.3 India In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.9 South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.1 South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.2 South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.9.2.1 South Korea 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.9.3 South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.10 Australia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.1 Australia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.2 Australia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.10.2.1 Australia 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.10.3 Australia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.4 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts To 2027
9.4.1 Overview
9.4.2 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.3 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.3.1 Middle East & Africa 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.4 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.4.5 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
9.4.6 South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.1 South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.2 South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.6.2.1 South Africa 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.6.3 South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.4.7 Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.1 Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.2 Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.7.2.1 Saudi Arabia 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.7.3 Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.4.8 UAE In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.1 UAE In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.2 UAE In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.8.2.1 UAE 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.8.3 UAE In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.5 South and Central America In Vitro Lung Model Market Revenue and Forecast To 2027
9.5.1 Overview
9.5.2 South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
9.5.3 South and Central America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.3.1 South and Central America 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.4 South and Central America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.5.5 South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027, By Country (%)
9.5.6 Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.1 Argentina In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
9.5.6.2 Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.6.2.1 Argentina 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.6.3 Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.5.7 Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.1 Brazil In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
9.5.7.2 Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.7.2.1 Brazil 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.7.3 Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10. In Vitro Lung Model Market- Industry Landscape
10.1 Overview
10.2 Growth Strategies in the In Vitro Lung Model Market, 2016-2019
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.1.1 Recent Organic Developments By Players In The In vitro lung model Market
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.1.1 Recent Inorganic Developments By Players In The In Vitro lung model Market
11. In Vitro Lung Model Market-Key Company Profiles
11.1 Epithelix Sàrl
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MATTEK
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 LONZA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 InSphero
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Information
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Emulate, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 AlveoliX AG
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PromoCell GmbH
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Merck KgaA
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Horizon Discovery Group plc
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product/ Services Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms
Note: Product cover images may vary from those shown
  • Epithelix Sàrl
  • MATTEK
  • LONZA
  • InSphero
  • Emulate, Inc.
  • AlveoliX AG
  • Thermo Fisher Scientific Inc
  • PromoCell GmbH
  • Merck KGaA
  • Horizon Discovery Group plc
Note: Product cover images may vary from those shown